GSK 376501
Alternative Names: 376501; GSK376501Latest Information Update: 28 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Class Antihyperglycaemics
- Mechanism of Action Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Type 2 diabetes mellitus